-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Reinstates Buy on Tarsus Pharmaceuticals, Announces $116 Price Target

Benzinga·09/24/2026 12:04:03
語音播報
Goldman Sachs analyst Andrea Newkirk reinstates Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and announces $116 price target.